Unlocking potential with the best learning and research solutions

Look Inside Transparency in Health and Health Care in the United States

Transparency in Health and Health Care in the United States
Law and Ethics

Editors:
Holly Fernandez Lynch, Perelman School of Medicine, University of Pennsylvania
I. Glenn Cohen, Petrie-Flom Center, Harvard Law School, Massachusetts
Carmel Shachar, Petrie-Flom Center, Harvard Law School, Massachusetts
Barbara J. Evans, University of Houston Law Center

Carmel Shachar, I. Glenn Cohen, Holly Fernandez Lynch, Barbara J. Evans, Abigail R. Moncrieff, Barry R. Furrow, Govind Persad, Oliver J. Kim, Luke Gelinas, Craig J. Konnoth, Richard S. Saver, Elizabeth Sepper, Kristin M. Madison, Ameet Sarpatwari, Jerry Avorn, Aaron S. Kesselheim, Marc A. Rodwin, Wendy Netter Epstein, Mark A. Hall, Holly Fernandez Lynch, Rachel E. Sachs, Thomas J. Hwang, Barbara E. Bierer, Mark Barnes, Rebecca Li, Stefano Marino, Spyridon Drosos, Gregory Curfman, Anthony W. Orlando, Arnold J. Rosoff, Michelle M. Mello, David M. Studdert, Brahmajee K. Nallamothu, Allen Kachalia, Sharona Hoffman, Jim Hawkins, Harlan M. Krumholz, Dov Fox, Erin C. Fuse Brown, Jaime S. King, Jennifer E. Miller, Holly Fernandez Lynch, David A. Hyman, William E. Kovacic

View all contributors

Date Published: June 2019
availability: In stock
format: Paperback
isbn: 9781108456937

Rate & review

Paperback

Add to wishlist

Other available formats:
Hardback, eBook

Looking for an inspection copy?

This title is not currently available on inspection

Description

Contents

Resources

Courses

About the Authors

Transparency is a concept that is becoming increasingly lauded as a solution to a host of problems in the American health care system. Transparency initiatives show great promise, including empowering patients and other stakeholders to make more efficient decisions, improve resource allocation, and better regulate the health care industry. Nevertheless, transparency is not a cure-all for the problems facing the modern health care system. The authors of this volume present a nuanced view of transparency, exploring ways in which transparency has succeeded and ways in which transparency initiatives have room for improvement. Working at the intersection of law, medicine, ethics, and business, the book goes beyond the buzzwords to the heart of transparency's transformative potential, while interrogating its obstacles and downsides. It should be read by anyone looking for a better understanding of transparency in the health care context.
- Provides a nuanced view of transparency, including how transparency for its own sake can be counterproductive
- Utilizes an interdisciplinary approach, bringing together experts from diverse fields to give readers a broad understanding of how transparency can be useful across industries
- Supplies suggestions and recommendations for policy makers, including concrete ways to implement or utilize transparent practices in positive ways
Read more
Customer reviews

Not yet reviewed
Be the first to review

Log in to review

Review was not posted due to profanity
×

, create a review

(If you're not , sign out)

Please enter the right captcha value

Please enter a star rating.

Your review must be a minimum of 12 words.

How do you rate this item?

Reviews must contain at least 12 words about the product.

×

Product details
- Date Published: June 2019
- format: Paperback
- isbn: 9781108456937
- length: 370 pages
- dimensions: 227 x 151 x 20 mm
- weight: 0.54kg
- availability: In stock
Table of Contents
Introduction Carmel Shachar, I. Glenn Cohen, Holly Fernandez Lynch and Barbara J. Evans
Part I. Transparency in Health and Health Care: Thematic Issues: Introduction Abigail R. Moncrieff
1. Smashing into windows: 'the limits of consumer sovereignty in health care' Barry R. Furrow
2. The interplay of privacy and transparency in health care: the HIPAA privacy rule as a case study Barbara J. Evans
3. Transparency tradeoffs: priority-setting, scarcity, and health fairness Govind Persad
4. Slightly hazy: transparency and the costs of too much information Oliver J. Kim
Part II. Transparency and Informed Consent: Introduction Luke Gelinas
5. Transparency versus informed consent: the patient/consumer paradigms Craig J. Konnoth
6. Transparency and financial conflicts: the uncertain case for sunshine Richard S. Saver
7. Making religion transparent: the substance, process, and efficacy of disclosing religious restrictions on care Elizabeth Sepper
Part III. Transparency and Economics: Health Care Costs and Billing: Introduction Kristin M. Madison
8. Transparency on prescription drug research expenditures: a lever for restraining pricing? Ameet Sarpatwari, Jerry Avorn and Aaron S. Kesselheim
9. Is pharmaceutical price transparency an effective means to reduce high prices and wide variations? Marc A. Rodwin
10. Price transparency: a contracts solution Wendy Netter Epstein
11. Solving surprise medical bills Mark A. Hall
Part IV. Transparency and Innovation: Introduction Holly Fernandez Lynch
12. Increasing the transparency of FDA review to enhance the innovation process Rachel E. Sachs and Thomas J. Hwang
13. Transparency and clinical trial data sharing: legal and policy issues Barbara E. Bierer, Mark Barnes and Rebecca Li
14. The European Medicines Agency's approach to transparency Stefano Marino and Spyridon Drosos
Part V. Transparency and Outcomes: Promoting Health and Safety: Introduction Gregory Curfman
15. The role of transparency in promoting healthy behaviors: pros, cons, and perils of information sharing to foster personal responsibility in health care Anthony W. Orlando and Arnold J. Rosoff
16. The role of transparency in patient safety improvement Michelle M. Mello, David M. Studdert, Brahmajee K. Nallamothu and Allen Kachalia
17. Personal health records as a tool for transparency in health care Sharona Hoffman
18. Nontransparency in electronic health record systems Jim Hawkins, Barbara J. Evans and Harlan M. Krumholz
19. Transparency challenges in reproductive health care Dov Fox
Part VI. Challenges in Promoting and Measuring Transparency in Health Care: Introduction I. Glenn Cohen
20. ERISA as a barrier for state health care transparency efforts Erin C. Fuse Brown and Jaime S. King
21. Transparency and data sharing in clinical research and Big Pharma Jennifer E. Miller
22. Promoting IRB transparency: about what, to whom, why, and how? Holly Fernandez Lynch
23. Using disclosure to regulate PBMs: the dark side of transparency David A. Hyman and William E. Kovacic.
Look Inside
Editors
Holly Fernandez Lynch, Perelman School of Medicine, University of Pennsylvania
Holly Fernandez Lynch Is the John Russell Dickson, MD Presidential Assistant Professor of Medical Ethics at the University of Pennsylvania's Perelman School of Medicine. She focuses her scholarly research on issues at the intersection of law, bioethics, and health policy, in particular the ethics and regulation of research with human subjects and conflicts of conscience in health care.
I. Glenn Cohen, Petrie-Flom Center, Harvard Law School, Massachusetts
I. Glenn Cohen is the James A. Attwood and Leslie Williams Professor of Law and Faculty Director of Petrie-Flom Center for Health Law, Biotechnology & Bioethics at Harvard Law School. He is one of the world's leading experts on the intersection of bioethics and the law, as well as health law. He is the author of more than 110 articles in venues like the New England Journal of Medicine, JAMA, Nature, and the Harvard Law Review, and the author, editor, or co-editor of twelve books.
Carmel Shachar, Petrie-Flom Center, Harvard Law School, Massachusetts
Carmel Shachar is the Executive Director of the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School. Carmel's scholarship focuses on law and health policy, in particular the regulation of access to care for vulnerable individuals, health care anti-discrimination law and policy, and the use of all-payer claims databases in health care research. Carmel is also a Lecturer at Law on Harvard Law School, where she co-teaches a course on Health Care Rights in the Twenty-First Century.
Barbara J. Evans, University of Houston Law Center
Barbara J. Evans is the Mary Ann and Lawrence E. Faust Professor of Law, Professor of Electrical and Computer Engineering, and Director of the Center for Biotechnology and Law at the University of Houston. Her research interests include data privacy and access, regulation of emerging biotechnologies and machine-learning software, and genomic civil rights.
Contributors
Carmel Shachar, I. Glenn Cohen, Holly Fernandez Lynch, Barbara J. Evans, Abigail R. Moncrieff, Barry R. Furrow, Govind Persad, Oliver J. Kim, Luke Gelinas, Craig J. Konnoth, Richard S. Saver, Elizabeth Sepper, Kristin M. Madison, Ameet Sarpatwari, Jerry Avorn, Aaron S. Kesselheim, Marc A. Rodwin, Wendy Netter Epstein, Mark A. Hall, Holly Fernandez Lynch, Rachel E. Sachs, Thomas J. Hwang, Barbara E. Bierer, Mark Barnes, Rebecca Li, Stefano Marino, Spyridon Drosos, Gregory Curfman, Anthony W. Orlando, Arnold J. Rosoff, Michelle M. Mello, David M. Studdert, Brahmajee K. Nallamothu, Allen Kachalia, Sharona Hoffman, Jim Hawkins, Harlan M. Krumholz, Dov Fox, Erin C. Fuse Brown, Jaime S. King, Jennifer E. Miller, Holly Fernandez Lynch, David A. Hyman, William E. Kovacic